Median Diagnostics Inc
233250
Company Profile
Business description
Median Diagnostics Inc is a Korea based company engaged in the human and animal disease diagnosis business, which falls within the in vitro diagnostics industry. In vitro diagnostic kits are defined as medical devices, reagents, calibrators, specimen containers, and other items that provide information for diagnosing, monitoring, or assessing the suitability of patients or animals by testing specimens such as tissue, blood, or urine in vitro.
Contact
878 Sunhwan-daero
Dongnae-myeon
Gangwon-do
Chuncheon-si200-883
KORT: +82 332440100
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
67
Stocks News & Analysis
stocks
Procter & Gamble earnings: Frigid sales and margins don’t suggest cracks in its standing
North America was a notable blemish, down 2% on an organic basis.
stocks
Our view on Santos after production is ramped up
Barossa at 75% capacity and Pikka undergoing commissioning.
stocks
GE Aerospace earnings: No good deed goes unpunished
We’ve raised our fair value estimate of GE Aerospace stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,189.90 | 15.70 | 0.17% |
| CAC 40 | 8,143.05 | 5.84 | -0.07% |
| DAX 40 | 24,900.71 | 44.24 | 0.18% |
| Dow JONES (US) | 49,098.71 | 285.30 | -0.58% |
| FTSE 100 | 10,143.44 | 6.61 | -0.07% |
| HKSE | 26,749.51 | 119.55 | 0.45% |
| NASDAQ | 23,501.24 | 65.22 | 0.28% |
| Nikkei 225 | 53,846.87 | 157.98 | 0.29% |
| NZX 50 Index | 13,460.43 | 12.19 | 0.09% |
| S&P 500 | 6,915.61 | 2.26 | 0.03% |
| S&P/ASX 200 | 8,860.10 | 15.00 | 0.17% |
| SSE Composite Index | 4,136.16 | 13.59 | 0.33% |